NCT01463150View on ClinicalTrials.gov

Prasugrel 5mg Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Aged ≥75 Years and/or Weighing <60 kg Post Percutaneous Coronary Intervention (PCI)

PHASE4CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Platelet Reactivity
Interventions
DRUG

Clopidogrel

Clopidogrel 150mg per day for 15 days

DRUG

Prasugrel

Prasugrel 5mg per day for 15 days

Trial Locations (1)

26500

Cardiology Department Patras University Hospital, Rio

All Listed Sponsors
lead

University of Patras

OTHER

NCT01463150 - Prasugrel 5mg Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Aged ≥75 Years and/or Weighing <60 kg Post Percutaneous Coronary Intervention (PCI) | Biotech Hunter | Biotech Hunter